VYNE

VYNE Therapeutics Inc.

Insider trading activity for VYNE Therapeutics Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 35 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Jul 29	RTW Fund Group GP, LLC	10% Owner	JOTHER◆	133,290	—	—	—	Open the original filing on SEC.gov
Jul 29	RTW Fund Group GP, LLC	10% Owner	JOTHER	133,290	—	—	-33.4%	Open the original filing on SEC.gov
Jul 27	Zeronda Tyler	Director	AGRANT◆	185,798	—	—	—	Open the original filing on SEC.gov
Jul 27	Ashiya Mona	Director	AGRANT◆	15,435	—	—	—	Open the original filing on SEC.gov
Jul 23	Zeronda Tyler	Chief Financial Officer	FTAX	22,516	$0.8976	$20.2K	-23.1%	Open the original filing on SEC.gov
Jul 23	Stuart Iain	Chief Scientific Officer	FTAX	15,405	$0.8976	$13.8K	-13.8%	Open the original filing on SEC.gov
Jul 23	Harsch Mutya	Chief Legal Officer and…	FTAX	22,516	$0.8976	$20.2K	-19.0%	Open the original filing on SEC.gov
Jul 23	Domzalski David	President and CEO	FTAX	79,391	$0.8976	$71.3K	-18.6%	Open the original filing on SEC.gov
Jun 30	Zeronda Tyler	Chief Financial Officer	FTAX	3,464	$0.6507	$2.3K	-3.4%	Open the original filing on SEC.gov
Jun 30	Stuart Iain	Chief Scientific Officer	FTAX	2,370	$0.6507	$1.5K	-2.1%	Open the original filing on SEC.gov
Jun 30	Harsch Mutya	Chief Legal Officer and…	FTAX	3,464	$0.6507	$2.3K	-2.8%	Open the original filing on SEC.gov
Jun 30	Domzalski David	President and CEO	FTAX	12,214	$0.6507	$7.9K	-2.8%	Open the original filing on SEC.gov
May 29	Domzalski David	President and CEO	AGRANT	30,791	$0.31	$9.5K	+7.5%	Open the original filing on SEC.gov
Mar 31	Zeronda Tyler	Chief Financial Officer	FTAX	4,007	$0.5975	$2.4K	-3.9%	Open the original filing on SEC.gov
Mar 31	Stuart Iain	Chief Scientific Officer	FTAX	2,876	$0.5975	$1.7K	-2.5%	Open the original filing on SEC.gov
Mar 31	Harsch Mutya	Chief Legal Officer and…	FTAX	4,007	$0.5975	$2.4K	-3.2%	Open the original filing on SEC.gov
Mar 31	Domzalski David	President and CEO	FTAX	14,232	$0.5975	$8.5K	-3.4%	Open the original filing on SEC.gov
Dec 31, 2025	Zeronda Tyler	Chief Financial Officer	FTAX	7,858	$0.5801	$4.6K	-7.0%	Open the original filing on SEC.gov
Dec 31, 2025	Stuart Iain	Chief Scientific Officer	FTAX	2,448	$0.5801	$1.4K	-2.1%	Open the original filing on SEC.gov
Dec 31, 2025	Harsch Mutya	Chief Legal Officer and…	FTAX	3,579	$0.5801	$2.1K	-2.8%	Open the original filing on SEC.gov
Dec 31, 2025	Domzalski David	President and CEO	FTAX	12,684	$0.5801	$7.4K	-3.0%	Open the original filing on SEC.gov
Dec 12, 2025	Little Elisabeth…	Director	AGRANT◆	20,000	—	—	—	Open the original filing on SEC.gov
Dec 12, 2025	Lepore Patrick G	Director	AGRANT◆	20,000	—	—	—	Open the original filing on SEC.gov
Dec 12, 2025	Basta Steven L	Director	AGRANT◆	20,000	—	—	—	Open the original filing on SEC.gov
Dec 12, 2025	Barbari Sharon	Director	AGRANT◆	20,000	—	—	—	Open the original filing on SEC.gov
Sep 30, 2025	Zeronda Tyler	Chief Financial Officer	FTAX	3,420	$0.335	$1.1K	-3.0%	Open the original filing on SEC.gov
Sep 30, 2025	Stuart Iain	Chief Scientific Officer	FTAX	2,453	$0.335	$822	-2.0%	Open the original filing on SEC.gov
Sep 30, 2025	Harsch Mutya	Chief Legal Officer and…	FTAX	3,581	$0.335	$1.2K	-2.7%	Open the original filing on SEC.gov
Sep 30, 2025	Domzalski David	President and CEO	FTAX	12,676	$0.335	$4.2K	-2.9%	Open the original filing on SEC.gov
Jun 30, 2025	Zeronda Tyler	Chief Financial Officer	FTAX	3,420	$1.65	$5.6K	-2.9%	Open the original filing on SEC.gov
Jun 30, 2025	Stuart Iain	Chief Scientific Officer	FTAX	2,453	$1.65	$4K	-2.0%	Open the original filing on SEC.gov
Jun 30, 2025	Harsch Mutya	Chief Legal Officer and…	FTAX	3,581	$1.65	$5.9K	-2.6%	Open the original filing on SEC.gov
Jun 30, 2025	Domzalski David	President and CEO	FTAX	12,676	$1.65	$20.9K	-2.8%	Open the original filing on SEC.gov
Jun 2, 2025	Harsch Mutya	Chief Legal Officer and…	AGRANT	1,145	$0.81	$927	+0.9%	Open the original filing on SEC.gov
Jun 2, 2025	Domzalski David	President and CEO	AGRANT	8,681	$0.81	$7K	+1.9%	Open the original filing on SEC.gov

JOTHER◆—

RTW Fund Group GP, LLC · 10% OwnerJul 29

133,290 sh

JOTHER—

RTW Fund Group GP, LLC · 10% OwnerJul 29

133,290 sh · -33.4% own

AGRANT◆—

Zeronda Tyler · DirectorJul 27

185,798 sh

AGRANT◆—

Ashiya Mona · DirectorJul 27

15,435 sh

FTAX$20.2K

Zeronda Tyler · Chief Financial…Jul 23

22,516 sh @ $0.8976 · -23.1% own

FTAX$13.8K

Stuart Iain · Chief Scientific…Jul 23

15,405 sh @ $0.8976 · -13.8% own

FTAX$20.2K

Harsch Mutya · Chief Legal…Jul 23

22,516 sh @ $0.8976 · -19.0% own

FTAX$71.3K

Domzalski David · President and CEOJul 23

79,391 sh @ $0.8976 · -18.6% own

FTAX$2.3K

Zeronda Tyler · Chief Financial…Jun 30

3,464 sh @ $0.6507 · -3.4% own

FTAX$1.5K

Stuart Iain · Chief Scientific…Jun 30

2,370 sh @ $0.6507 · -2.1% own

FTAX$2.3K

Harsch Mutya · Chief Legal…Jun 30

3,464 sh @ $0.6507 · -2.8% own

FTAX$7.9K

Domzalski David · President and CEOJun 30

12,214 sh @ $0.6507 · -2.8% own

AGRANT$9.5K

Domzalski David · President and CEOMay 29

30,791 sh @ $0.31 · +7.5% own

FTAX$2.4K

Zeronda Tyler · Chief Financial…Mar 31

4,007 sh @ $0.5975 · -3.9% own

FTAX$1.7K

Stuart Iain · Chief Scientific…Mar 31

2,876 sh @ $0.5975 · -2.5% own

FTAX$2.4K

Harsch Mutya · Chief Legal…Mar 31

4,007 sh @ $0.5975 · -3.2% own

FTAX$8.5K

Domzalski David · President and CEOMar 31

14,232 sh @ $0.5975 · -3.4% own

FTAX$4.6K

Zeronda Tyler · Chief Financial…Dec 31, 2025

7,858 sh @ $0.5801 · -7.0% own

FTAX$1.4K

Stuart Iain · Chief Scientific…Dec 31, 2025

2,448 sh @ $0.5801 · -2.1% own

FTAX$2.1K

Harsch Mutya · Chief Legal…Dec 31, 2025

3,579 sh @ $0.5801 · -2.8% own

FTAX$7.4K

Domzalski David · President and CEODec 31, 2025

12,684 sh @ $0.5801 · -3.0% own

AGRANT◆—

Little Elisabeth… · DirectorDec 12, 2025

20,000 sh

AGRANT◆—

Lepore Patrick G · DirectorDec 12, 2025

20,000 sh

AGRANT◆—

Basta Steven L · DirectorDec 12, 2025

20,000 sh

AGRANT◆—

Barbari Sharon · DirectorDec 12, 2025

20,000 sh

FTAX$1.1K

Zeronda Tyler · Chief Financial…Sep 30, 2025

3,420 sh @ $0.335 · -3.0% own

FTAX$822

Stuart Iain · Chief Scientific…Sep 30, 2025

2,453 sh @ $0.335 · -2.0% own

FTAX$1.2K

Harsch Mutya · Chief Legal…Sep 30, 2025

3,581 sh @ $0.335 · -2.7% own

FTAX$4.2K

Domzalski David · President and CEOSep 30, 2025

12,676 sh @ $0.335 · -2.9% own

FTAX$5.6K

Zeronda Tyler · Chief Financial…Jun 30, 2025

3,420 sh @ $1.65 · -2.9% own

FTAX$4K

Stuart Iain · Chief Scientific…Jun 30, 2025

2,453 sh @ $1.65 · -2.0% own

FTAX$5.9K

Harsch Mutya · Chief Legal…Jun 30, 2025

3,581 sh @ $1.65 · -2.6% own

FTAX$20.9K

Domzalski David · President and CEOJun 30, 2025

12,676 sh @ $1.65 · -2.8% own

AGRANT$927

Harsch Mutya · Chief Legal…Jun 2, 2025

1,145 sh @ $0.81 · +0.9% own

AGRANT$7K

Domzalski David · President and CEOJun 2, 2025

8,681 sh @ $0.81 · +1.9% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 34 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →